Inflammatory Age: How Inflammaging Markers May Predict Biological Age

Inflammatory Age and Inflammaging: An Emerging Biological Age Marker

Chronological age alone does not tell us much about biological function. Two people born on the same day may have very different risks of age-related disease. In recent years, researchers have developed a range of biological age measures - including epigenetic clocks, transcriptomic clocks, and now inflammatory age, or iAge. Research suggests inflammatory age may offer a complementary lens on aging by focusing on the immune system and chronic low-grade inflammation.

This article reviews the concept of inflammaging, the development of the iAge biomarker, what studies indicate about its predictive value, and the practical implications for readers interested in biological age tracking.

What Is Inflammaging?

“Inflammaging” is a term coined to describe the chronic, low-grade, sterile inflammation that appears to increase with age. Research suggests this state is characterized by elevated levels of circulating cytokines such as IL-6, TNF-alpha, and CRP, without an identifiable acute infection.

Why Inflammation Matters for Aging

Chronic low-grade inflammation has been linked to many age-related conditions, including cardiovascular disease, neurodegeneration, sarcopenia, and frailty. A 2019 review in Nature Medicine described chronic inflammation as a common thread across diseases of aging.

Research suggests inflammaging may emerge from multiple sources: accumulation of senescent cells that secrete inflammatory molecules, age-related changes in the gut microbiome, cellular debris from damaged tissues, and altered immune cell function.

The iAge Biomarker

Development of the Inflammatory Aging Clock

A 2021 study published in Nature Aging introduced an inflammatory aging clock called iAge. Researchers used deep learning to analyze a large panel of circulating immune markers from over a thousand adults and trained a model to predict chronological age. The difference between predicted inflammatory age and actual chronological age appeared to be associated with multimorbidity, frailty, and immune cell composition.

Research suggests iAge may serve as a composite summary of an individual’s inflammatory burden, distilling many markers into a single interpretable number.

What iAge May Predict

Studies indicate iAge may correlate with:

• Frailty in older adults
• Multimorbidity burden
• Immune aging markers such as CD8+ T cell exhaustion
• Centenarian status in exceptionally long-lived individuals
• Cardiovascular risk parameters

Research suggests iAge is not a perfect predictor of any single outcome but may add value alongside other biological age measures.

Inflammatory Age vs Other Biological Age Clocks

Epigenetic Clocks

Epigenetic clocks such as Horvath, Hannum, PhenoAge, and GrimAge use DNA methylation patterns to estimate biological age. Research suggests they capture different aspects of aging compared to inflammatory markers. Some people may appear “older” on one type of clock and “younger” on another.

PhenoAge and Biomarker-Based Measures

PhenoAge, derived from a small set of clinical blood markers, overlaps conceptually with inflammatory age in using circulating biomarkers. Research suggests iAge may be more specifically tuned to immune-system aging, while PhenoAge covers broader metabolic and organ function signals.

Functional and Fitness Measures

Fitness age estimates, such as those based on VO2 max, offer another lens. Research suggests combining multiple lenses - epigenetic, inflammatory, metabolic, and functional - may provide the most complete picture of biological aging.

Lifestyle Factors That May Influence Inflammatory Age

While randomized trials specifically targeting iAge remain limited, many interventions that lower general inflammation may also influence inflammatory age. Research suggests:

• Regular exercise is associated with lower circulating IL-6 and CRP.
• Mediterranean-style diets appear to lower systemic inflammation markers.
• Adequate sleep may reduce inflammatory cytokine levels.
• Stress management may modulate inflammatory responses.
• Weight management may reduce adipose-tissue-derived inflammation.

These interventions are generally considered safe and broadly supportive of health, so they may be reasonable starting points regardless of whether a given person tracks iAge directly.

Availability of iAge Testing

As of 2026, iAge-style measurement is primarily available through research settings, specialty clinics, and a small number of direct-to-consumer services. Research suggests broader commercial availability may follow if the biomarker continues to validate in larger cohorts.

Some clinical laboratories offer panels of individual inflammation markers such as CRP, IL-6, and TNF-alpha, which can provide related information even without a formal iAge score.

What This Means for You

For readers interested in inflammatory age:

• Consider inflammation as one lens among several biological age measures.
• Focus on lifestyle fundamentals: Exercise, diet, sleep, and stress management.
• Be cautious about isolated marker chasing: Single inflammation numbers fluctuate.
• Work with a clinician to interpret biomarker panels and rule out non-aging causes.

Research suggests tracking trends over time may be more meaningful than any single measurement, and context with other biomarkers is important.

Limitations and Future Research

The current inflammatory age evidence base has several limitations:

• Cohort diversity is still limited; more global data are needed.
• Cross-validation with other biological age measures is ongoing.
• Intervention trials targeting iAge specifically are scarce.
• Reference ranges may vary by assay platform and population.

Future research may clarify how iAge changes in response to lifestyle interventions, how it integrates with epigenetic clocks, and whether it can guide meaningful clinical decisions.

The Bottom Line

Inflammatory age, or iAge, is a promising biomarker that research suggests may offer complementary information about immune-system aging and risk of frailty and multimorbidity. It is not a replacement for epigenetic clocks or clinical evaluation, but it may add value in a comprehensive biological age assessment. Lifestyle factors that lower general inflammation may also lower iAge, though large intervention trials are still needed. Consult your healthcare provider for interpretation and guidance.

This content is for educational purposes only and is not medical advice.